All News
Revolution Medicines Obliterates Launch Expectations With $198 Million in Five Weeks — But Can a Still-Unprofitable Biotech Justify a $47 Billion Bet?
Shares of Revolution Medicines surged 10.2% to $220.00 after the company reported that its pancreatic cancer drug generated $197.6 million in net revenue...
Phibro Animal Health first quarter 2027 revenue beats expectations as company maintains annual guidance
Phibro Animal Health reported first quarter 2027 net sales of $386.8 million, surpassing the consensus estimate of $382.4 million, while adjusted diluted EPS...
Magnite Blew Past Every Q3 Target — But Can Streaming Ads Sustain This Breakneck Pace?
Shares surged nearly 10% after the close on November 4 as Magnite delivered a quarter that beat expectations across the board, raising the question of whether...
TaskUs Smashes Q3 Estimates on AI Surge, but Can a Sub-Billion-Dollar Company Keep Winning the AI Outsourcing Race?
Shares of TaskUs jumped 8.2% to $9.34 after the outsourcing specialist delivered a record third quarter that blew past Wall Street's expectations, raising the...
Xperi Inc. beats third quarter 2026 revenue and earnings estimates as advertising revenue surged 280%
Xperi Inc. reported third quarter 2026 revenue of $114.0 million, slightly ahead of the $111.5 million analyst estimate. The company achieved a non-GAAP...
Veracyte Beat Wall Street's Numbers — So Why Did Investors Erase $700 Million in Market Value Overnight?
Shares of Veracyte cratered 17.2% to $43.50 after the cancer diagnostics company reported Q3 results on November 4 that, on paper, looked solid — but came...
MagnaChip's third quarter 2026 results missed estimates as revenue declined 4% year-over-year
MagnaChip reported third quarter 2026 revenue of $44.0 million, hitting the midpoint of internal guidance but falling short of analyst consensus. Performance...
🔴 Zillow Group is trading 17.4% down in after-hours trading on November 4, 2026, after revenue miss
Zillow Group is trading 17.4% lower at $28.00 in after-hours trading following third-quarter results reported after the November 4, 2026, market close, with...
🔴 Veracyte is trading 17.17% down in after-hours trading after narrowing FY2026 revenue outlook
Following the November 4 regular-session close, Veracyte is trading at $43.50, down 17.17%, after management narrowed the upper end of its FY2026 revenue...
🟢 USG.NZ is trading 3.07% up on November 4, 2026, as midterm sweep eased election uncertainty
USG.NZ is trading at NZD 16.80, up 3.07%, in line with stronger U.S. market sentiment after Democrats’ midterm sweep eased election uncertainty. - No clear...
🟢 Taskus is trading 8.2% up in after-hours trading after record Q3 revenue beat estimates
Taskus is trading at $9.34 (+8.23%) in after-hours trading after its November 4, 2026, earnings release reported record Q3 revenue of $314.7 million, beating...
GRAIL's Cancer Test Sells More Units But Less Revenue — Is the Growth Story Breaking Down?
Shares of GRAIL cratered 12.5% to $125.75 after the cancer-detection company's third-quarter revenue landed far below what Wall Street expected, raising hard...
Aris Mining's third quarter 2026 revenue of $295M significantly beat estimates despite higher AISC
Aris Mining reported strong top-line results for the third quarter of 2026, with revenue significantly exceeding analyst expectations due to high realized gold...
🔴 SiTime is trading 7% down in after-hours trading on November 4, 2026 despite revenue beat
SiTime is trading at $374.90, down 7.03% after hours; available coverage does not establish why shares fell despite Q3 revenue of $298.7 million beating...
🔴 Snap is trading 9.6% down in after-hours trading as revenue slightly missed consensus
Snap is trading 9.6% down at $5.34 in after-hours trading after total revenue slightly missed consensus in its November 4, 2026, Q3 report. - The report...
🟢 Sezzle is trading 9.76% up in after-hours trading after third-quarter revenue and EPS beat estimates
Sezzle is trading at $150.04, up +9.76% in after-hours trading after third-quarter revenue and non-GAAP EPS beat expectations. - Revenue was $166.5 million,...
🟢 Revolution Medicines is trading 10.2% up in after-hours trading after RASONQUE revenue topped estimates
Revolution Medicines is trading up 10.2% at $220.00 after RASONQUE generated $197.6 million in net product revenue in its first five weeks, far above analysts’...
🟢 Rapid7 is trading 16.5% up in after-hours trading after Q3 earnings beat
Rapid7 is trading 16.48% higher at $17.52 in after-hours trading on November 4 after beating Q3 earnings estimates. - Revenue was $212.4 million, versus...
🔴 Qualcomm is trading 6.03% down in after-hours trading after handset revenue fell 26%
Qualcomm is trading 6.03% down at $162.74 after its November 4, 2026, earnings release, as handset revenue weakness weighed on shares. - Revenue was $10.32...
Goodyear's third quarter 2026 revenue beat estimates while adjusted EPS missed on market weakness
Goodyear reported third quarter 2026 net sales of $4.5 billion, slightly exceeding estimates despite a 2.3% year-over-year decline. The company posted an...